Transplant Matches Identified by Ultra-High-Resolution HLA Typing Associated with Higher Patient Survival Rates

In a retrospective study, Anthony Nolan Research Institute found SMRT® Sequencing identified superior HLA matches, which are critical in determining successful transplant outcomesMENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that a retrospective study conducted... Read more

Fabric Genomics Announces AI-based ACMG Classification Solution for Genetic Testing with Hereditary Panels

Enables clinical laboratories to drastically decrease turnaround and scale test volume April 01, 2019 10:02 PM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–Fabric Genomics will launch a new solution this week for variant interpretation and clinical reporting, allowing clinical laboratories to dramatically accelerate turnaround times. This new software solution, called Fabric Hereditary Panels with ACE (AI Classification... Read more

Canopy Biosciences Launches New Technology Vastly Improving Sensitivity of Next Generation Sequencing

ST. LOUIS, March 29, 2019 — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today the launch of RareSeq, a new error corrected sequencing service that vastly increases the sensitivity of genetic testing over traditional methods. This technology, exclusively licensed from Washington University and developed by Todd... Read more

Illumina Files Patent Infringement Suit Against BGI in Germany

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit against BGI Group’s subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany. The complaint alleges that BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents, infringe EP 1 530 578 B1. This patent covers... Read more

QIAGEN launches novel liquid biopsy solutions and NGS panels with seamlessly integrated bioinformatics to support advances in cancer research

Germantown, Maryland, and Hilden, Germany, March 28, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of new solutions designed to advance cancer research as part of its highlights at the American Association for Cancer Research (AACR) 2019 Annual Meeting from March 29 to April 3, 2019, in Atlanta, Georgia. More... Read more

Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling

Integrated Workflow Combines NanoString’s GeoMx DSP High-Plex RNA Assays and Bio-Techne’s Highly Sensitive RNAscope Imaging Reagent Portfolio SEATTLE and MINNEAPOLIS, March 28, 2019 (GLOBE NEWSWIRE) — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and NanoString Technologies, Inc.(NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic... Read more

Promega Awarding $10,000 Grants to Labs Working with Real-Time PCR Reagents

Madison, WI USA. (March 27, 2019) Promega Corporation is seeking three labs working with real-time PCR to receive $10,000 in free reagents, access to a VIP Technical Service Mentor providing comprehensive PCR support and specialized training on real-time PCR techniques. Applications are open to any research scientist or student enrolled in a life science undergraduate, graduate... Read more

Illumina and the Lundbeck Foundation GeoGenetics Centre Collaborate to Generate One of the Largest Ancient Genome Datasets to Decode the Genetic Origins and Evolution of Mental Health Issues

SAN DIEGO–(BUSINESS WIRE)–Illumina (NASDAQ:ILMN) and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, Denmark partner to explore the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens. One of the first projects of its kind worldwide, the endeavor aims to acquire new knowledge in terms of the medical... Read more

NanoString Technologies Announces Closing of Public Offering of 5,175,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares

SEATTLE, March 25, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 5,175,000 shares of its common stock at a price to the public of $23.00 per share pursuant to its shelf registration statement. NanoString sold 3,175,000 shares of... Read more

NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock

SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $23.00 per share pursuant to its shelf registration statement. NanoString will sell 2,500,000 shares of common... Read more